Deal Summary

Mighty Therapeutics

credit facility

To secure access to additional capital necessary to reach cash flow positivity

K2 HealthVentures

Deal Notes:

Industry:

Biotechnology

Role:

Lender

Event:

Recapitalization

Recent Deal Announcements